Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors-Reference-Cited by-同舟云学术

Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors

Published:2015-06 Issue: Volume:29 Page:S9-S18
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Santagostino Elena,Escobar Miguel,Ozelo Margareth,Solimeno Luigi,Arkhammar Per,Lee Hye Youn,Rosu Gabriela,Giangrande Paul

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference57 articles.

1. Treatment of hemophilia: a review of current advances and ongoing issues;Coppola;J Blood Med,2010

2. Inhibitors in Hemophilia: a primer;DiMichele,2008

3. International workshop on immune tolerance induction: consensus recommendations;DiMichele;Haemophilia,2007

4. Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomes;Shapiro;Ther Adv Drug Saf,2011

5. Importance of rapid bleeding control in haemophilia complicated by inhibitors;Berntorp;Haemophilia,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single‐arm, open‐label study;Haemophilia;2024-02-05

2. Perioperative management of patients with hemostatic system disorders. Methodological recommendations of the All-Russian public organization “Federation of Anesthesiologists and Reanimatologists” and the National Association of Specialists in Thrombosis, Clinical Hemostasiology and Hemorheology;Annals of Critical Care;2024-01-27

3. Risk Factors for Amputation in the Surgical Treatment of Hemophilic Osteoarthropathy: A 20-Year Single-Center Report;Pain Research and Management;2022-03-28

4. Emicizumab treatment and monitoring in a paediatric cohort: real‐world data;British Journal of Haematology;2020-07-12

5. Patients with hemophilia A and inhibitors: prevention and evolving treatment paradigms;Expert Review of Hematology;2020-03-18